Whitehawk Therapeutics, Inc. (WHWK) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on March 18, 2025, by Whitehawk Therapeutics, Inc. (formerly Aadi Bioscience, Inc.). The filing primarily addresses a corporate name change and references the announcement of financial results for the fiscal year ended December 31, 2024.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Item 2.02 states that the Company issued a press release regarding its fiscal year 2024 results, which is attached as Exhibit 99.1, but the specific financial data points are not included in the body of this 8-K document.
Material Changes
- Corporate Name Change: The Board of Directors approved an amendment to the Certificate of Incorporation to change the company's name from Aadi Bioscience, Inc. to Whitehawk Therapeutics, Inc.
- Effective Date: The name change was filed with the Delaware Secretary of State and became effective on March 18, 2025.
- Bylaws Amendment: The Company's bylaws were amended and restated solely to reflect the new name.
- Shareholder Rights: The filing explicitly states that the name change did not require stockholder approval and will not affect the rights of security holders.
Guidance, Outlook, and Risks
The filing does not contain specific management commentary, forward-looking guidance, or a detailed discussion of risks within the text provided. It notes that the information in Item 2.02 and Item 9.01, including the attached press release, is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific fiscal year 2024 financial results, as they are not detailed in this 8-K.
- Confirm the ticker symbol remains WHWK on The Nasdaq Stock Market LLC following the name change.
- Verify that the name change has been updated in brokerage accounts and trading platforms.
- Examine the full text of the Amended and Restated Certificate of Incorporation (Exhibit 3.1) and Bylaws (Exhibit 3.2) for any clauses beyond the name change.